Genetic Technologies Ltd Half-Yearly Financial Report for 2025
Key points
- Revenue for the half-year ended 31 December 2025 was NIL due to divestment of trading businesses
- Loss before income tax was $239,902, down 92% from the previous period
- Net liabilities as at 31 December 2025 were $229,902
- Company remains non-operating and ASX-suspended shell
- No dividends were paid or declared for the current or previous financial period
Full summary
Genetic Technologies Ltd's half-yearly financial report for the period ended 31 December 2025 shows that the company did not generate any revenue for the period as it completed the divestment of its trading businesses during FY25. The company reported a loss before income tax of $239,902, down 92% from the previous period. The net liabilities as at 31 December 2025 were $229,902, with cash and cash equivalents amounting to $10,257. The company remains a non-operating ASX-suspended shell and did not pay any dividends for the current or previous financial period.
Sign in for more about this company, including guidance changes and other insights.
Sign in